These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32646255)

  • 1. Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene Therapy.
    Salami CO; Jackson K; Jose C; Alyass L; Cisse GI; De BP; Stiles KM; Chiuchiolo MJ; Sondhi D; Crystal RG; Kaminsky SM
    Hum Gene Ther; 2020 Aug; 31(15-16):819-827. PubMed ID: 32646255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified mouse model of Friedreich's ataxia with conditional
    Perfitt TL; Huichalaf C; Gooch R; Kuperman A; Ahn Y; Chen X; Ullas S; Hirenallur-Shanthappa D; Zhan Y; Otis D; Whiteley LO; Bulawa C; Martelli A
    Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H357-H369. PubMed ID: 38038720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's Ataxia.
    Munoz-Zuluaga C; Gertz M; Yost-Bido M; Greco A; Gorman N; Chen A; Kooner V; Rosenberg JB; De BP; Kaminsky SM; Borczuk A; Ricart Arbona RJ; Martin HR; Monette S; Khanna R; Barth JA; Crystal RG; Sondhi D
    Hum Gene Ther; 2023 Jul; 34(13-14):605-615. PubMed ID: 37166361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.
    Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H
    Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.
    Piguet F; de Montigny C; Vaucamps N; Reutenauer L; Eisenmann A; Puccio H
    Mol Ther; 2018 Aug; 26(8):1940-1952. PubMed ID: 29853274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future Prospects of Gene Therapy for Friedreich's Ataxia.
    Ocana-Santero G; Díaz-Nido J; Herranz-Martín S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM
    PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells.
    Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA
    Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation.
    Whitnall M; Suryo Rahmanto Y; Sutak R; Xu X; Becker EM; Mikhael MR; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9757-62. PubMed ID: 18621680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy.
    Li J; Li Y; Wang J; Gonzalez TJ; Asokan A; Napierala JS; Napierala M
    Hum Gene Ther; 2020 Aug; 31(15-16):839-851. PubMed ID: 32527155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency.
    Sayles NM; Napierala JS; Anrather J; Diedhiou N; Li J; Napierala M; Puccio H; Manfredi G
    Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37691621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cardiac Calcium Handling Machinery is Remodeled in Friedreich's Ataxia.
    Czornobil R; Abou-Assali O; Remily-Wood E; Lynch DR; Noujaim SF; Chidipi B
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of the novel NAD
    Chiang S; Kalinowski DS; Dharmasivam M; Braidy N; Richardson DR; Huang MLH
    Pharmacol Res; 2020 May; 155():104680. PubMed ID: 32032665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and processing of mature human frataxin after gene therapy in mice.
    Rojsajjakul T; Selvan N; De B; Rosenberg JB; Kaminsky SM; Sondhi D; Janki P; Crystal RG; Mesaros C; Khanna R; Blair IA
    Sci Rep; 2024 Apr; 14(1):8391. PubMed ID: 38600238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
    Lim F; Palomo GM; Mauritz C; Giménez-Cassina A; Illana B; Wandosell F; Díaz-Nido J
    Mol Ther; 2007 Jun; 15(6):1072-8. PubMed ID: 17375064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia.
    Chandran V; Gao K; Swarup V; Versano R; Dong H; Jordan MC; Geschwind DH
    Elife; 2017 Dec; 6():. PubMed ID: 29257745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.
    Martelli A; Friedman LS; Reutenauer L; Messaddeq N; Perlman SL; Lynch DR; Fedosov K; Schulz JB; Pandolfo M; Puccio H
    Dis Model Mech; 2012 Nov; 5(6):860-9. PubMed ID: 22736457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
    Jasoliya M; Sacca F; Sahdeo S; Chedin F; Pane C; Brescia Morra V; Filla A; Pook M; Cortopassi G
    PLoS One; 2019; 14(6):e0217776. PubMed ID: 31158268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich's ataxia.
    Chang JC; Ryan MR; Stark MC; Liu S; Purushothaman P; Bolan F; Johnson CA; Champe M; Meng H; Lawlor MW; Halawani S; Ngaba LV; Lynch DR; Davis C; Gonzalo-Gil E; Lutz C; Urbinati F; Medicherla B; Fonck C
    Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101193. PubMed ID: 38352270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.
    Vyas PM; Tomamichel WJ; Pride PM; Babbey CM; Wang Q; Mercier J; Martin EM; Payne RM
    Hum Mol Genet; 2012 Mar; 21(6):1230-47. PubMed ID: 22113996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.